Paxman AB Total Liabilities

Latest as of September 2025: Skr59.89 Million SEK ≈ $6.45 Million USD

Paxman AB total liabilities. Based on the latest financial reports, Paxman AB (PAX) has total liabilities worth Skr59.89 Million SEK (≈ $6.45 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check PAX asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Paxman AB (2016–2024)

Total liabilities of Paxman AB from 2016 to 2024. This chart illustrates how Paxman AB's total liabilities have evolved over time, based on quarterly financial data.

Paxman AB Competitors by Total Liabilities

The table below lists competitors of Paxman AB ranked by their total liabilities.

Company Country Total Liabilities
Settlebank Corporation
KQ:234340
Korea ₩343.70 Billion
Acme United Corporation
NYSE MKT:ACU
USA $78.52 Million
TIL Limited
NSE:TIL
India Rs-1.11 Billion
Batisoke Soke Cimento Sanayi TAS
IS:BSOKE
Turkey TL3.94 Billion
St Augustine Gold and Copper Ltd
TO:SAU
Canada CA$2.51 Million
Silver Mountain Resources Inc
V:AGMR
Canada CA$31.60 Million
Wei Chih Steel Industrial Co Ltd
TW:2028
Taiwan NT$3.59 Billion
Sonmez Filament Sentetik Iplik ve Elyaf Sanayi AS
IS:SONME
Turkey TL675.76 Million

Liability Composition Analysis (2016–2024)

This chart breaks down Paxman AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Paxman AB asset portfolio.

Liquidity & Leverage Metrics

Paxman AB Total Liabilities Ratios Explained

Paxman AB total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 4.68 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.14 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.12 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Paxman AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Paxman AB (2016–2024)

The table below shows the annual total liabilities of Paxman AB from 2016 to 2024.

Year Total Liabilities Change
2024-12-31 Skr63.24 Million
≈ $6.81 Million
+42.08%
2023-12-31 Skr44.51 Million
≈ $4.79 Million
-25.52%
2022-12-31 Skr59.76 Million
≈ $6.43 Million
+47.25%
2021-12-31 Skr40.59 Million
≈ $4.37 Million
-38.62%
2020-12-31 Skr66.12 Million
≈ $7.12 Million
+16.80%
2019-12-31 Skr56.61 Million
≈ $6.09 Million
+86.56%
2018-12-31 Skr30.34 Million
≈ $3.27 Million
+136.33%
2017-12-31 Skr12.84 Million
≈ $1.38 Million
+2.41%
2016-12-31 Skr12.54 Million
≈ $1.35 Million
--

About Paxman AB

ST:PAX Sweden Medical Devices
Market Cap
$158.29 Million
Skr1.47 Billion SEK
Market Cap Rank
#17274 Global
#294 in Sweden
Share Price
Skr63.20
Change (1 day)
-0.16%
52-Week Range
Skr43.55 - Skr68.40
All Time High
Skr83.80
About

Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has collaborated with the University of Huddersfield and the University of Leeds to develop a wearable medical cooling device; and the National University Hospital of … Read more